國新文化(600636.SH)擬向三愛富新材料轉讓振氟新材料65%股權
格隆匯11月23日丨國新文化(600636.SH)公佈,2020年10月14日,公司在上海聯合產權交易所對振氟新材料65%股權正式掛牌出售。2020年11月12日,上海華誼三愛富新材料有限公司(以下簡稱“三愛富新材料”)摘牌,以摘牌價格1.98億元取得振氟新材料65%股權。
2020年11月23日,公司第九屆董事會第二十三次會議審議通過了《關於公開掛牌方式轉讓子公司股權暨關聯交易的議案》,同意公司將持有的振氟新材料65%股權轉讓給三愛富新材料。
三愛富新材料系持有公司5%以上股份股東上海華誼的全資子公司,根據《上海證券交易所股票上市規則》,為公司的關聯方,本次交易尚需提交公司股東大會審議通過。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.